Alembic Limited at the Board of Directors meeting held on 12 May, 2023, approved the appointment of Dr. Girish Hirode as an Independent Director of the Company effective from the date of the upcoming Annual General Meeting (AGM).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
99.41 INR | +0.74% | -2.08% | +9.69% |
05-30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
05-13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+9.69% | 304M | |
-11.78% | 26.36B | |
+3.75% | 25.9B | |
+27.31% | 25.67B | |
+17.46% | 24.19B | |
+36.75% | 20.37B | |
+10.32% | 20.63B | |
-4.55% | 18.43B | |
+3.23% | 16.74B | |
+38.43% | 16.42B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- News Alembic Limited
- Alembic Limited Approves Appointment of Girish Hirode as Independent Director